SGSM1
gene geneOn this page
Also known as KIAA1941
Summary
SGSM1 (small G protein signaling modulator 1, HGNC:29410) is a protein-coding gene on chromosome 22q11.23, encoding Small G protein signaling modulator 1 (Q2NKQ1). Interacts with numerous Rab family members, functioning as Rab effector for some, and as GTPase activator for others.
Enables GTPase activator activity and small GTPase binding activity. Predicted to act upstream of or within positive regulation of transcription by RNA polymerase II. Located in cytoplasmic vesicle membrane and cytosol.
Source: NCBI Gene 129049 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 180 total
- MANE Select transcript:
NM_001098497
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29410 |
| Approved symbol | SGSM1 |
| Name | small G protein signaling modulator 1 |
| Location | 22q11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1941 |
| Ensembl gene | ENSG00000167037 |
| Ensembl biotype | protein_coding |
| OMIM | 611417 |
| Entrez | 129049 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 6 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000400358, ENST00000400359, ENST00000470591, ENST00000473458, ENST00000480523, ENST00000610372, ENST00000872030, ENST00000930603, ENST00000945264
RefSeq mRNA: 4 — MANE Select: NM_001098497
NM_001039948, NM_001098497, NM_001098498, NM_133454
CCDS: CCDS46674, CCDS46675, CCDS74834
Canonical transcript exons
ENST00000400358 — 25 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001563186 | 24806211 | 24806344 |
| ENSE00001564168 | 24924186 | 24927578 |
| ENSE00001691958 | 24844897 | 24844972 |
| ENSE00003467853 | 24867093 | 24867160 |
| ENSE00003479251 | 24868376 | 24868539 |
| ENSE00003480530 | 24855285 | 24855430 |
| ENSE00003488189 | 24912643 | 24912752 |
| ENSE00003489374 | 24901833 | 24901957 |
| ENSE00003492521 | 24886600 | 24886728 |
| ENSE00003517128 | 24847634 | 24847796 |
| ENSE00003527545 | 24897972 | 24898559 |
| ENSE00003535233 | 24884053 | 24884198 |
| ENSE00003536158 | 24859716 | 24859840 |
| ENSE00003555394 | 24868723 | 24868855 |
| ENSE00003561747 | 24855549 | 24855680 |
| ENSE00003581952 | 24876577 | 24876715 |
| ENSE00003605150 | 24806441 | 24806484 |
| ENSE00003605788 | 24854996 | 24855063 |
| ENSE00003616985 | 24850280 | 24850432 |
| ENSE00003647504 | 24879462 | 24879526 |
| ENSE00003657550 | 24919826 | 24919993 |
| ENSE00003672696 | 24895223 | 24895291 |
| ENSE00003687103 | 24905105 | 24905187 |
| ENSE00003691067 | 24917658 | 24917754 |
| ENSE00003691966 | 24893431 | 24893613 |
Expression profiles
Bgee: expression breadth ubiquitous, 197 present calls, max score 93.04.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2645 / max 57.6478, expressed in 396 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 191435 | 0.9163 | 324 |
| 191434 | 0.3482 | 166 |
Top tissues by expression
252 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cardiac muscle of right atrium | UBERON:0003379 | 93.04 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 92.54 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 88.05 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 87.22 | gold quality |
| postcentral gyrus | UBERON:0002581 | 86.53 | gold quality |
| entorhinal cortex | UBERON:0002728 | 86.22 | gold quality |
| hypothalamus | UBERON:0001898 | 85.75 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 85.48 | gold quality |
| cerebellar cortex | UBERON:0002129 | 85.46 | gold quality |
| cardiac atrium | UBERON:0002081 | 85.19 | gold quality |
| cerebellum | UBERON:0002037 | 85.14 | gold quality |
| primary visual cortex | UBERON:0002436 | 84.99 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.98 | gold quality |
| right atrium auricular region | UBERON:0006631 | 84.95 | gold quality |
| pancreatic ductal cell | CL:0002079 | 84.44 | silver quality |
| parietal lobe | UBERON:0001872 | 84.06 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 83.65 | gold quality |
| nucleus accumbens | UBERON:0001882 | 83.26 | gold quality |
| frontal cortex | UBERON:0001870 | 82.94 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.65 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.57 | gold quality |
| pituitary gland | UBERON:0000007 | 82.55 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 82.47 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.40 | gold quality |
| neocortex | UBERON:0001950 | 82.38 | gold quality |
| right frontal lobe | UBERON:0002810 | 82.15 | gold quality |
| cerebral cortex | UBERON:0000956 | 81.75 | gold quality |
| adenohypophysis | UBERON:0002196 | 81.20 | gold quality |
| occipital lobe | UBERON:0002021 | 81.05 | gold quality |
| brain | UBERON:0000955 | 80.98 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.83 |
| E-MTAB-6142 | no | 0.89 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
104 targeting SGSM1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-6755-5P | 99.95 | 65.59 | 464 |
| HSA-MIR-5010-5P | 99.94 | 64.11 | 705 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-4492 | 99.87 | 68.25 | 3611 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-6515-3P | 99.82 | 68.19 | 1933 |
| HSA-MIR-6739-5P | 99.80 | 67.87 | 2806 |
Literature-anchored findings (GeneRIF, showing 4)
- Identification of novel protein SGSM1 which modulate small G protein (RAP and RAB)-mediated signaling pathway. (PMID:17509819)
- These data show that RUTBC2 can act as a Rab36 GAP in cells and suggest that RUTBC2 links Rab9A function to Rab36 function in the endosomal system. (PMID:22637480)
- Reduced SGSM1 Stability is associated with Nasopharyngeal Carcinoma Metastasis. (PMID:30573520)
- Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas. (PMID:35484511)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | sgsm1a | ENSDARG00000028857 |
| danio_rerio | sgsm1b | ENSDARG00000075376 |
| mus_musculus | Sgsm1 | ENSMUSG00000042216 |
| rattus_norvegicus | Sgsm1 | ENSRNOG00000000708 |
Paralogs (45): RABGAP1 (ENSG00000011454), TBC1D22A (ENSG00000054611), TBC1D22B (ENSG00000065491), TBC1D1 (ENSG00000065882), EVI5 (ENSG00000067208), TBC1D25 (ENSG00000068354), TBC1D2 (ENSG00000095383), TBC1D10A (ENSG00000099992), SGSM3 (ENSG00000100359), TBC1D17 (ENSG00000104946), TBC1D13 (ENSG00000107021), TBC1D12 (ENSG00000108239), TBC1D9 (ENSG00000109436), TBC1D30 (ENSG00000111490), TBC1D15 (ENSG00000121749), TBC1D5 (ENSG00000131374), TBC1D14 (ENSG00000132405), TBC1D8B (ENSG00000133138), TBC1D4 (ENSG00000136111), GRTP1 (ENSG00000139835), SGSM2 (ENSG00000141258), EVI5L (ENSG00000142459), TBCK (ENSG00000145348), USP6NL (ENSG00000148429), RABGAP1L (ENSG00000152061), TBC1D21 (ENSG00000167139), TBC1D2B (ENSG00000167202), TBC1D16 (ENSG00000167291), TBC1D10B (ENSG00000169221), TBC1D10C (ENSG00000175463), TBC1D28 (ENSG00000189375), TBC1D9B (ENSG00000197226), TBC1D8 (ENSG00000204634), TBC1D26 (ENSG00000214946), TBC1D3G (ENSG00000260287), TBC1D3K (ENSG00000273513), TBC1D3H (ENSG00000274226), TBC1D3D (ENSG00000274419), TBC1D3L (ENSG00000274512), TBC1D3 (ENSG00000274611)
Protein
Protein identifiers
Small G protein signaling modulator 1 — Q2NKQ1 (reviewed: Q2NKQ1)
Alternative names: RUN and TBC1 domain-containing protein 2
All UniProt accessions (2): Q2NKQ1, A0A087X241
UniProt curated annotations — full annotation on UniProt →
Function. Interacts with numerous Rab family members, functioning as Rab effector for some, and as GTPase activator for others. Promotes GTP hydrolysis by RAB34 and RAB36. Probably functions as a GTPase effector with RAB9A and RAB9B; does not stimulate GTP hydrolysis with RAB9A and RAB9B.
Subunit / interactions. Interacts with RAB9A (GTP-bound form) and RAB9B (GTP-bound form); has much lower affinity for GDP-bound RAB9A and RAB9B. Interacts with RAB3A, RAB4A, RAB5A, RAB8A, RAB11A, RAP1A, RAP1B, RAP2A and RAP2B. No interaction with RAB27A.
Subcellular location. Golgi apparatus. trans-Golgi network. Cytoplasmic vesicle membrane. Cytoplasm.
Tissue specificity. Mainly expressed in brain, heart and testis.
Similarity. Belongs to the RUTBC family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q2NKQ1-1 | 1 | yes |
| Q2NKQ1-3 | 2 | |
| Q2NKQ1-4 | 3 |
RefSeq proteins (4): NP_001035037, NP_001091967, NP_001091968, NP_597711 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000195 | Rab-GAP-TBC_dom | Domain |
| IPR004012 | Run_dom | Domain |
| IPR021935 | SGSM1/2_RBD | Domain |
| IPR035969 | Rab-GAP_TBC_sf | Homologous_superfamily |
| IPR037213 | Run_dom_sf | Homologous_superfamily |
| IPR037745 | SGSM1/2 | Domain |
| IPR047344 | RUN_SGSM1 | Domain |
Pfam: PF00566, PF02759, PF12068
UniProt features (21 total): compositionally biased region 7, region of interest 5, splice variant 4, domain 2, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q2NKQ1-F1 | 66.94 | 0.34 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 62 (showing top):
GOMF_GTPASE_BINDING, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, MIKKELSEN_MEF_HCP_WITH_H3K27ME3, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C, GLI1_TARGET_GENES, HAND1_TARGET_GENES, MIER1_TARGET_GENES, RLF_TARGET_GENES, SFMBT1_TARGET_GENES, ZNF213_TARGET_GENES, ZNF322_TARGET_GENES, ZNF37A_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (3): GTPase activator activity (GO:0005096), small GTPase binding (GO:0031267), protein binding (GO:0005515)
GO Cellular Component (6): cytoplasm (GO:0005737), Golgi apparatus (GO:0005794), cytosol (GO:0005829), cytoplasmic vesicle membrane (GO:0030659), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| cytoplasm | 3 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| GTPase binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
| vesicle membrane | 1 |
| cytoplasmic vesicle | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
810 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SGSM1 | SGSM3 | Q96HU1 | 911 |
| SGSM1 | RAB4A | P20338 | 782 |
| SGSM1 | RAP1B | P09526 | 762 |
| SGSM1 | RAP2A | P10114 | 752 |
| SGSM1 | RAB11A | P24410 | 697 |
| SGSM1 | RAB3A | P20336 | 688 |
| SGSM1 | RAB8A | P24407 | 686 |
| SGSM1 | RAP1A | P10113 | 663 |
| SGSM1 | RAP2B | P17964 | 652 |
| SGSM1 | RAB5A | P20339 | 629 |
| SGSM1 | RAB36 | O95755 | 541 |
| SGSM1 | DPYSL4 | O14531 | 502 |
| SGSM1 | TBC1D21 | Q8IYX1 | 444 |
| SGSM1 | TBC1D19 | Q8N5T2 | 436 |
| SGSM1 | C22orf15 | Q8WYQ4 | 434 |
| SGSM1 | WSCD2 | Q2TBF2 | 434 |
IntAct
11 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CETN2 | SFI1 | psi-mi:“MI:0914”(association) | 0.740 |
| SGSM1 | CETN1 | psi-mi:“MI:0915”(physical association) | 0.660 |
| CETN1 | SFI1 | psi-mi:“MI:0914”(association) | 0.640 |
| SGSM1 | CETN2 | psi-mi:“MI:0914”(association) | 0.530 |
| SGSM1 | CETN3 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC4A5 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (21): SGSM1 (Two-hybrid), SGSM1 (Two-hybrid), SGSM1 (Two-hybrid), SGSM1 (Affinity Capture-MS), SGSM1 (Affinity Capture-RNA), SGSM1 (Affinity Capture-MS), SGSM1 (Two-hybrid), SGSM1 (Two-hybrid), CETN1 (Two-hybrid), OCIAD1 (Affinity Capture-MS), RANBP3 (Affinity Capture-MS), CETN2 (Affinity Capture-MS), ABCB10 (Affinity Capture-MS), PDGFRL (Affinity Capture-MS), ACADVL (Affinity Capture-MS)
ESM2 similar proteins: A0A1L8F1M4, A0A8M9QN10, A0JMQ9, A6NIR3, A8DZE6, A8WH69, B2KF05, F1QCY8, O43147, O43900, O54880, P0C6P5, P59729, P97433, Q13009, Q18PD9, Q2NKQ1, Q32L09, Q3U5C7, Q58D79, Q5EB20, Q5PQS0, Q5U464, Q60592, Q6IVY4, Q6P0Q8, Q6ZQF7, Q6ZUJ8, Q71QF9, Q768S4, Q7T2V3, Q7TNN8, Q7TSI1, Q7ZVP1, Q803A0, Q80U12, Q80VL3, Q80Y24, Q8BPQ7, Q8BRB7
Diamond homologs: A1A5B6, O43147, P09379, P48365, Q2NKQ1, Q3MII6, Q6FWI1, Q80U12, Q8BPQ7, Q8BYH7, Q8TBP0, Q8TC07, Q94BY9, Q9CXF4, Q9HA65, Q9UUH7, I2HAA0, Q09830, Q6BU76, Q28CB1, Q8R3D1, Q9NVG8, P48566, Q12344
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
180 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 153 |
| Likely benign | 9 |
| Benign | 3 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4454 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:24806481:GGAG:G | donor_gain | 1.0000 |
| 22:24806482:GAGG:G | donor_gain | 1.0000 |
| 22:24806484:GGTG:G | donor_loss | 1.0000 |
| 22:24844970:GTG:G | donor_gain | 1.0000 |
| 22:24844973:G:GG | donor_gain | 1.0000 |
| 22:24844973:G:T | donor_loss | 1.0000 |
| 22:24844974:T:A | donor_loss | 1.0000 |
| 22:24847793:GCGC:G | donor_gain | 1.0000 |
| 22:24847795:GC:G | donor_gain | 1.0000 |
| 22:24850269:T:A | acceptor_gain | 1.0000 |
| 22:24850428:AGCAG:A | donor_loss | 1.0000 |
| 22:24850429:GCAG:G | donor_gain | 1.0000 |
| 22:24850430:CAGG:C | donor_loss | 1.0000 |
| 22:24850431:AGGTG:A | donor_loss | 1.0000 |
| 22:24850432:GG:G | donor_loss | 1.0000 |
| 22:24850433:GTGAG:G | donor_loss | 1.0000 |
| 22:24850434:T:A | donor_loss | 1.0000 |
| 22:24855301:A:AG | acceptor_gain | 1.0000 |
| 22:24855302:G:GG | acceptor_gain | 1.0000 |
| 22:24855302:GA:G | acceptor_gain | 1.0000 |
| 22:24855429:GT:G | donor_gain | 1.0000 |
| 22:24855430:TG:T | donor_loss | 1.0000 |
| 22:24855431:G:GA | donor_loss | 1.0000 |
| 22:24855431:G:GG | donor_gain | 1.0000 |
| 22:24855537:A:AG | acceptor_gain | 1.0000 |
| 22:24855547:A:AG | acceptor_gain | 1.0000 |
| 22:24855548:G:GG | acceptor_gain | 1.0000 |
| 22:24855677:GCCG:G | donor_gain | 1.0000 |
| 22:24859713:CAG:C | acceptor_gain | 1.0000 |
| 22:24859714:AGA:A | acceptor_gain | 1.0000 |
AlphaMissense
7263 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:24844902:G:C | K23N | 1.000 |
| 22:24844902:G:T | K23N | 1.000 |
| 22:24844918:G:C | A29P | 1.000 |
| 22:24844937:T:A | V35D | 1.000 |
| 22:24850378:C:A | A134D | 1.000 |
| 22:24855287:G:A | G176R | 1.000 |
| 22:24855287:G:C | G176R | 1.000 |
| 22:24855335:T:A | W192R | 1.000 |
| 22:24855335:T:C | W192R | 1.000 |
| 22:24855655:G:A | G259D | 1.000 |
| 22:24859740:G:T | G276W | 1.000 |
| 22:24859741:G:A | G276E | 1.000 |
| 22:24859747:T:C | L278P | 1.000 |
| 22:24859753:T:C | L280P | 1.000 |
| 22:24859785:T:A | W291R | 1.000 |
| 22:24859785:T:C | W291R | 1.000 |
| 22:24867143:T:C | L326P | 1.000 |
| 22:24867148:T:C | C328R | 1.000 |
| 22:24868403:T:A | V341D | 1.000 |
| 22:24868439:T:C | F353S | 1.000 |
| 22:24868469:T:C | L363P | 1.000 |
| 22:24868478:T:C | L366P | 1.000 |
| 22:24868508:T:C | L376S | 1.000 |
| 22:24868522:T:A | W381R | 1.000 |
| 22:24868522:T:C | W381R | 1.000 |
| 22:24868820:T:C | F419S | 1.000 |
| 22:24879503:T:C | I546T | 1.000 |
| 22:24879512:G:T | R549I | 1.000 |
| 22:24879517:T:C | F551L | 1.000 |
| 22:24879519:C:A | F551L | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000030597 (22:24875331 G>T), RS1000038528 (22:24900800 C>G), RS1000110273 (22:24917145 G>A), RS1000126232 (22:24806086 G>A), RS1000127392 (22:24890780 G>A,T), RS1000148278 (22:24881530 C>T), RS1000150185 (22:24820669 G>A), RS1000155615 (22:24842124 C>T), RS1000196154 (22:24893698 C>CT), RS1000211332 (22:24923630 A>C,T), RS1000231973 (22:24831764 G>A,C), RS1000289122 (22:24906475 C>T), RS1000307858 (22:24923341 G>A), RS1000317173 (22:24911573 G>A), RS1000371763 (22:24812808 C>T)
Disease associations
OMIM: gene MIM:611417 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002481_6 | Acne (severe) | 6.000000e-07 |
| GCST003542_202 | Night sleep phenotypes | 3.000000e-06 |
| GCST004030_19 | Primary sclerosing cholangitis | 3.000000e-08 |
| GCST006138_18 | Resting-state electroencephalogram vigilance | 3.000000e-06 |
| GCST006631_52 | Nicotine dependence and major depression (severity of comorbidity) | 9.000000e-06 |
| GCST007160_34 | Refractive astigmatism | 4.000000e-07 |
| GCST009863_27 | Insulin-related traits (multivariate analysis) | 5.000000e-09 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004357 | electroencephalogram measurement |
| EFO:0007006 | depressive symptom measurement |
| EFO:0009262 | nicotine dependence symptom count |
| EFO:0004467 | insulin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Nickel | decreases expression | 2 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | increases expression | 1 |
| Cisplatin | affects expression | 1 |
| Estradiol | decreases expression | 1 |
| Potassium Dichromate | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.